MD Anderson Research Highlights for January 22, 2025
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Novel allogeneic NK cell therapy from induced pluripotent stem cells shows encouraging efficacy in...
ExxonMobil donates $10 million to fund MD Anderson-led Be Well™ Beaumont initiative
In an effort to improve public health and reduce cancer risk in East Texas, leaders in Beaumont are working with The University of Texas...
Chances of quitting smoking improve with integrated care, including medication and counseling
Smokers undergoing lung cancer screening may have the best chance of quitting if they receive integrated care, which includes medication and...
MD Anderson Research Highlights for January 9, 2025
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Neutrophils help cancer cells colonize abdominal fat
The omentum - a fatty tissue that suspends...
MD Anderson and Myriad Genetics form strategic alliance to evaluate clinical utility of Myriad’s molecular residual disease assay
The University of Texas MD Anderson Cancer Center and Myriad Genetics, Inc. today announced a five-year strategic alliance to accelerate the...